MX395082B - Composicion para uso en la prevencion o tratamiento de la salmonelosis - Google Patents

Composicion para uso en la prevencion o tratamiento de la salmonelosis

Info

Publication number
MX395082B
MX395082B MX2020005837A MX2020005837A MX395082B MX 395082 B MX395082 B MX 395082B MX 2020005837 A MX2020005837 A MX 2020005837A MX 2020005837 A MX2020005837 A MX 2020005837A MX 395082 B MX395082 B MX 395082B
Authority
MX
Mexico
Prior art keywords
salmonellosis
polysaccharides
composition
prevention
treatment
Prior art date
Application number
MX2020005837A
Other languages
English (en)
Other versions
MX2020005837A (es
Inventor
Maria Tzoumaki
Ruud Albers
Original Assignee
Nutrileads B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrileads B V filed Critical Nutrileads B V
Publication of MX2020005837A publication Critical patent/MX2020005837A/es
Publication of MX395082B publication Critical patent/MX395082B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/50—Polysaccharides, gums
    • A23V2250/502—Gums
    • A23V2250/5072—Pectine, pectinate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Husbandry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pediatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La invención se refiere a una composición para su uso en la prevención o tratamiento de salmonelosis en animales, dicho uso comprende administrar la composición al animal, en la que la composición contiene al menos 0,01% en peso de materia seca de polisacáridos de ramnogalacturonano I (RG-I) que tiene un peso molecular de más de 2 kDa y que tiene un esqueleto que consiste en restos de ácido galacturónico y restos de ramnosa, dichos restos de ramnosa están contenidos en restos de alfa (1?4) -galacturónico-alfa (1?2) ramnosa, en la que la relación molar de restos de ácido galacturónico a restos de ramnosa en los polisacáridos RG-I está dentro del intervalo de 50:1 a 1:1. El uso de polisacáridos RG-I en el tratamiento o prevención de la salmonelosis ofrece una alternativa para el uso generalizado de antibióticos. Además, estos polisacáridos RG-I se pueden usar para prevenir o tratar la salmonelosis causada por cepas de Salmonella con resistencia a los antibióticos.
MX2020005837A 2017-12-04 2017-12-04 Composicion para uso en la prevencion o tratamiento de la salmonelosis MX395082B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2017/050807 WO2019112418A1 (en) 2017-12-04 2017-12-04 Composition for use in the prevention or treatment of salmonellosis

Publications (2)

Publication Number Publication Date
MX2020005837A MX2020005837A (es) 2020-10-28
MX395082B true MX395082B (es) 2025-03-21

Family

ID=60788655

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020005837A MX395082B (es) 2017-12-04 2017-12-04 Composicion para uso en la prevencion o tratamiento de la salmonelosis

Country Status (10)

Country Link
US (1) US11524025B2 (es)
EP (1) EP3720449B1 (es)
JP (1) JP2021514383A (es)
KR (1) KR102561466B1 (es)
CN (1) CN111447935A (es)
AU (1) AU2017441954A1 (es)
BR (1) BR112020011197A2 (es)
CA (1) CA3084044A1 (es)
MX (1) MX395082B (es)
WO (1) WO2019112418A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023379925A1 (en) * 2022-11-15 2025-06-05 Nutrileads B.V. Prebiotic composition for stabilizing a healthy gut microbiota
CN118581050B (zh) * 2024-06-05 2025-04-22 青岛农业大学 一株沙门氏菌噬菌体vB-SenS-JZ291及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492350B2 (en) 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
DE10019076A1 (de) 2000-04-06 2001-10-18 Lang Christine Verwendung von Polygalakturoniden als Lebensmittelzusatzstoffe
DE10057976B4 (de) 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
WO2004084652A1 (en) 2003-03-26 2004-10-07 Novozymes A/S Method of producing vegetable puree
EP1765874A1 (en) * 2004-03-26 2007-03-28 Glycogenesys, Inc. Modified pectins, compositions and methods related thereto
WO2006114778A1 (en) 2005-04-26 2006-11-02 Teagasc- The Agriculture And Food Development Authority Probiotic composition suitable for animals
KR20150064233A (ko) 2007-09-27 2015-06-10 바이오테라, 인크. 상부 호흡기 감염 증상 및 심리적 웰빙의 베타-글루칸 처리
EP2510014A1 (en) * 2009-12-11 2012-10-17 Unilever NV Polysaccharide suitable to modulate immune response
WO2011136634A1 (en) 2010-04-26 2011-11-03 N.V. Nutricia Preventing salmonella infection induced weight loss
JP5996837B2 (ja) 2010-05-28 2016-09-21 小林製薬株式会社 インフルエンザウイルスの感染抑制剤
US9951148B2 (en) * 2011-04-29 2018-04-24 Nutrileads B.V. Method for isolation of polysaccharides
CN102784193A (zh) 2012-08-16 2012-11-21 魏舒畅 采用耦合技术制备红芪提取物的方法
EP2983662A4 (en) 2013-03-15 2016-09-21 MicroBiome Therapeutics LLC FIBER OF ACTIVATED SOYBEAN SLEEVES
US9393259B2 (en) 2013-03-21 2016-07-19 Lonza Ltd. Composition comprising arabinogalactan and polyphenols from larch trees
JP6233032B2 (ja) 2013-06-05 2017-11-22 デクセリアルズ株式会社 光学活性化合物の製造方法
WO2015192247A1 (en) 2014-06-21 2015-12-23 The Royal Institution For The Advancement Of Learning/Mcgill University Enzymatic production of prebiotic oligosaccharides from potato pulp
GB201502668D0 (en) 2015-02-17 2015-04-01 Glycomar Ltd And Albert Bartlett & Sons Airdrie Ltd Method for isolation of polysaccharides
KR101774566B1 (ko) 2015-11-05 2017-09-04 한국식품연구원 면역기능 증진 활성이 우수한 효소처리 보리잎 유래 다당 분획물 및 이의 용도

Also Published As

Publication number Publication date
EP3720449C0 (en) 2024-04-17
WO2019112418A1 (en) 2019-06-13
AU2017441954A1 (en) 2020-07-16
MX2020005837A (es) 2020-10-28
US11524025B2 (en) 2022-12-13
CN111447935A (zh) 2020-07-24
EP3720449A1 (en) 2020-10-14
CA3084044A1 (en) 2019-06-13
JP2021514383A (ja) 2021-06-10
KR102561466B1 (ko) 2023-07-31
US20200289545A1 (en) 2020-09-17
KR20200097291A (ko) 2020-08-18
AU2017441954A2 (en) 2020-07-23
EP3720449B1 (en) 2024-04-17
BR112020011197A2 (pt) 2020-11-17

Similar Documents

Publication Publication Date Title
CY1125083T1 (el) Υποκατεστημενα βενζαμιδια 1,3-θειαζολ-2-υλιου
CR20210578A (es) Derivados de ácido itacónico y usos de estos en el tratamiento de una enfermedad inflamatoria asociada con una respuesta inmunotaria indeseable
CO2018013557A2 (es) Composiciones que comprenden cepas bacterianas
MX2019000795A (es) Composiciones de limpieza liquidas con sistema antibacteriano y metodo para su fabricacion.
BR112018013011A2 (pt) composições de alimento para animais de estimação
MY198425A (en) Glp-1 Compositions and uses Thereof
MX2021002478A (es) Prebiotico para el tratamiento de trastornos asociados a la composicion o funcionalidad alterada del microbioma intestinal.
CO2019008987A2 (es) Mejoras en o con respecto a compuestos orgánicos
DOP2015000234A (es) COMPOSICIONES DE ARNi CONTRA EL COMPONENTE C5 DEL COMPLEMENTO Y METODOS PARA SU USO.
EA201690712A1 (ru) Композиции из фрагментов белков шелка и изделия, изготовленные из них
EA200970390A1 (ru) Макромолекулярные аминофенольные антиокислительные композиции, способы их производства и применения
BR112017004925A2 (pt) composição e método
BR112017002836A2 (pt) composições de terpolímero com clareza e brilho aprimorados
CO2017009910A2 (es) Éteres de celulosa esterificada de gelificación
MX383530B (es) Novedoso bacteriófago de e. coli enteroinvasiva esc-cop-4 y su uso para inhibir la proliferación de e. coli enteroinvasiva
CL2019001746A1 (es) Amidas aromáticas de ácido carboxílico
MX2017001085A (es) Uso de senales visuales para mejorar composiciones repelentes de aves.
BR112015000381A2 (pt) mistura de sobremesa congelada usando produtos de proteína de leguminosas
MX2021012676A (es) Composiciones probioticas y usos de las mismas.
MX392458B (es) Composición de caucho de nitrilo, composición de látex de caucho de nitrilo altamente saturado, y caucho reticulado
MX2019007216A (es) Caucho de nitrilo que contiene grupo carboxilo, metodo para producir el mismo, composicion de caucho de nitrilo reticulable, y caucho reticulado.
MX2019000637A (es) Composiciones detergentes que comprenden polisacaridos de ultra bajo peso molecular.
MX2020005837A (es) Composicion para uso en la prevencion o tratamiento de la salmonelosis.
PE20191580A1 (es) Procedimiento para utilizar el relave como material de construccion dandole caracteristicas impermeabilizantes y reduciendo su agrietamiento
BR112017019534A2 (pt) substrato fibroso para captura de bacterias gram-negativas